These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 33367302)

  • 41. Prognostic value of metabolic tumor volume of pretreatment
    Kumasaka S; Nakajima T; Arisaka Y; Tokue A; Achmad A; Fukushima Y; Shimizu K; Kaira K; Higuchi T; Tsushima Y
    BMC Med Imaging; 2018 Nov; 18(1):46. PubMed ID: 30477476
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Semiquantitative parameters of
    Liao XH; Wang RF; Liu M; Chen XQ; Xiong Y; Nong L; Yin L; Zhang BY; DU YJ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Oct; 53(2):246-254. PubMed ID: 33879893
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The prognostic role of FDG PET/CT before combined radio-chemotherapy in anal cancer patients.
    Leccisotti L; Manfrida S; Barone R; Ripani D; Tagliaferri L; Masiello V; Privitera V; Gambacorta MA; Rufini V; Valentini V; Giordano A
    Ann Nucl Med; 2020 Jan; 34(1):65-73. PubMed ID: 31728763
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic Value of Volume-Based Metabolic Parameters Obtained by 18F-FDG-PET/CT in Patients With Locally Advanced Squamous Cell Cervical Carcinoma.
    Liang Y; Li X; Wan H; Fang Y; Zheng R; Zhang W; Liu Y; Chen C; Wu N
    J Comput Assist Tomogr; 2018; 42(3):429-434. PubMed ID: 29369948
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic value of FDG-PET and DWI in breast cancer.
    Kitajima K; Miyoshi Y; Yamano T; Odawara S; Higuchi T; Yamakado K
    Ann Nucl Med; 2018 Jan; 32(1):44-53. PubMed ID: 29134565
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pretreatment quantitative
    Gencturk M; Ozturk K; Koksel Y; Li F; Cayci Z
    Clin Imaging; 2019; 53():17-24. PubMed ID: 30308429
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Prognostic value of (18)F-fluorodeoxyglucose (FDG) positron emission tomography-computed tomography (PET-CT) in extensive-stage small cell lung cancer].
    Ding CY; Guo Z; Li YY; Li TR
    Zhonghua Zhong Liu Za Zhi; 2017 Nov; 39(11):828-834. PubMed ID: 29151289
    [No Abstract]   [Full Text] [Related]  

  • 48. Relationship between 18F-fluorodeoxyglucose PET/computed tomography metabolic parameters and clinicopathology in endometrial cancer.
    Yao X; Tan X; Zhang H; Yuan H; Zeng B; He L; Jiang L
    Nucl Med Commun; 2022 Dec; 43(12):1233-1238. PubMed ID: 36345768
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Relation of whole-body metabolic tumor volume and total lesion glycolysis on fluorodeoxyglucose PET/computed tomography with clinical and laboratory parameters in newly diagnosed multiple myeloma.
    Goksel S; Ilkkilic K; Bulbul O; Akdogan E
    Nucl Med Commun; 2022 Oct; 43(10):1077-1083. PubMed ID: 36006402
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Correlation of breast cancer subtypes, based on estrogen receptor, progesterone receptor, and HER2, with functional imaging parameters from ⁶⁸Ga-RGD PET/CT and ¹⁸F-FDG PET/CT.
    Yoon HJ; Kang KW; Chun IK; Cho N; Im SA; Jeong S; Lee S; Jung KC; Lee YS; Jeong JM; Lee DS; Chung JK; Moon WK
    Eur J Nucl Med Mol Imaging; 2014 Aug; 41(8):1534-43. PubMed ID: 24652232
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic significance of metabolic parameters measured by
    Chang H; Lee SJ; Lim J; Lee JS; Kim YJ; Lee WW
    J Cancer Res Clin Oncol; 2019 May; 145(5):1361-1367. PubMed ID: 30900157
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Artificial intelligence-based, volumetric assessment of the bone marrow metabolic activity in [
    Sachpekidis C; Enqvist O; Ulén J; Kopp-Schneider A; Pan L; Mai EK; Hajiyianni M; Merz M; Raab MS; Jauch A; Goldschmidt H; Edenbrandt L; Dimitrakopoulou-Strauss A
    Eur J Nucl Med Mol Imaging; 2024 Jul; 51(8):2293-2307. PubMed ID: 38456971
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Correlation of the value of 18F-FDG uptake, described by SUVmax, SUVavg, metabolic tumour volume and total lesion glycolysis, to clinicopathological prognostic factors and biological subtypes in breast cancer.
    Kajáry K; Tőkés T; Dank M; Kulka J; Szakáll S; Lengyel Z
    Nucl Med Commun; 2015 Jan; 36(1):28-37. PubMed ID: 25299471
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic value of
    Lee JR; Almuhaimid TM; Roh JL; Oh JS; Kim SJ; Kim JS; Choi SH; Nam SY; Kim SY
    J Surg Oncol; 2018 Sep; 118(4):644-650. PubMed ID: 30132891
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Value of Intratumoral Metabolic Heterogeneity and Quantitative
    Pinho DF; King B; Xi Y; Albuquerque K; Lea J; Subramaniam RM
    AJR Am J Roentgenol; 2020 Apr; 214(4):908-916. PubMed ID: 32069078
    [No Abstract]   [Full Text] [Related]  

  • 56. Which of the fluorine-18 fluorodeoxyglucose positron emission tomography/computerized tomography parameters are better associated with prognostic factors in breast cancer?
    Önner H; Canaz F; Dinçer M; Işiksoy S; Sivrikoz İA; Entok E; Erkasap S
    Medicine (Baltimore); 2019 May; 98(22):e15925. PubMed ID: 31145358
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic role of baseline
    Albano D; Bosio G; Camoni L; Farina M; Re A; Tucci A; Giubbini R; Bertagna F
    Hematol Oncol; 2019 Feb; 37(1):39-46. PubMed ID: 30299563
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic Value of the Volumetric Parameters of Dual-Time-Point
    Okazaki E; Seura H; Hasegawa Y; Okamura T; Fukuda H
    AJR Am J Roentgenol; 2019 Dec; 213(6):1366-1373. PubMed ID: 31509426
    [No Abstract]   [Full Text] [Related]  

  • 59. Prognostic value of preoperative metabolic tumor volume and total lesion glycolysis measured by 18F-FDG PET/CT in salivary gland carcinomas.
    Ryu IS; Kim JS; Roh JL; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    J Nucl Med; 2013 Jul; 54(7):1032-8. PubMed ID: 23670902
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis on Preoperative ¹⁸F-FDG PET/CT in Patients with Pancreatic Cancer.
    Lee JW; Kang CM; Choi HJ; Lee WJ; Song SY; Lee JH; Lee JD
    J Nucl Med; 2014 Jun; 55(6):898-904. PubMed ID: 24711649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.